AI Drug Discovery’s $2B Moment, CPUs Return, and Deepfakes Go Real-Time

In today’s AI in Flow, Claire and Peter break down Alphabet’s Isomorphic Labs reportedly nearing a $2B+ raise—signalling serious momentum (and pricing power) for AI-led drug discovery. They also explore why server CPUs are regaining importance alongside GPUs as inference and agentic workloads drive heterogeneous data centres across x86 and Arm.Plus: Airbnb says AI agents now produce around 60% of new code under human supervision and its support bot resolves 40% of tickets—clear evidence that agentic AI is already operational, not hypothetical. The episode also covers record highs for AI-linked markets, reports of OpenAI and Anthropic pursuing enterprise services joint ventures, India’s use of AI to combat health insurance fraud (with auditability front and centre), a Florida deepfake FaceTime scam that shows synthetic media risk is now offline too, and research suggesting LLMs may be flattening writing style—making brand voice and human editorial control more important than ever.About Six & FlowSix & Flow is a digital transformation consultancy helping businesses adapt, grow, and thrive in a fast-changing world. We specialise in AI, CRM, and revenue operations, blending strategy, technology, and creativity to deliver measurable impact. From scaling startups to global enterprises, we partner with ambitious teams to unlock growth through smart automation, customer-centric marketing, and forward-thinking sales enablement. Learn more at sixandflow.com. Hosted on Acast. See acast.com/privacy for more information.